Correspondingly, the 4 biomarkers ER, PgR, Ki-67 and HER2 showed a stable and accurate potential to predict BC patients cluster ́ membership according to several prediction algorithms (Table 2). This evidence concerns the gene ERBB2 and breast cancer.